期刊
MOLECULAR THERAPY
卷 1, 期 4, 页码 323-329出版社
ACADEMIC PRESS INC
DOI: 10.1006/mthe.2000.0045
关键词
AAV2; liver; T cell independent; neutralizing antibodies; gene therapy
资金
- NHLBI NIH HHS [P01 HL59407-01] Funding Source: Medline
- NICHD NIH HHS [P01 HD32649-05] Funding Source: Medline
- NIDDK NIH HHS [P30 DK47757-06] Funding Source: Medline
Vectors based on adeno-associated viruses (AAV) type 2 show promise for treating chronic diseases because transgene expression appears to be stable. This study evaluated the impact of humoral immunity to the capsid proteins on vector uptake by hepatocytes following an intravascular approach. Route of vector administration in mice had a qualitative effect on antivector B cell responses. Administration of vector into the tail vein resulted in T-cell-dependent (TD) B cell responses that were completely inhibited with depleting CD4 antibody. Delivery of vector into the portal circulation via the spleen yielded B cell response that were partially T cell independent (TI) rendering strategies based on T cell inhibition ineffective in allowing vector readministration. The TI B cell response was short lived in comparison to the TD response. Rhesus monkeys produced a B cell memory response to intraportal vector which appeared to be T cell dependent based on Ig isotypes. Gene therapy strategies that require AAV vector readministration should consider vector biodistribution and its impact on B cell activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据